Stay updated on Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial
Sign up to get notified when there's something new on the Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial page.

Latest updates to the Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial page
- Check6 days agoChange DetectedThe study history now shows the latest revision as v3.4.3, replacing v3.4.2. This change is limited to version labeling and does not modify the study's content or behavior.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry (v3.4.2) was added to the record history, and the prior funding-status notice and revision v3.4.1 were removed.SummaryDifference0.7%

- Check41 days agoChange DetectedA general notice about government funding and the NIH Clinical Center’s operating status has been added to the page. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check48 days agoChange DetectedThe history view now includes a glossary toggle and green/red color-coded highlights to distinguish additions and deletions. Footer notes were updated to show Revision: v3.4.0, with the previous No FEAR Act text and revision (v3.3.4) replaced.SummaryDifference0.9%

- Check84 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check113 days agoChange DetectedThe page history shows a new site revision label (Revision: v3.3.2) added and an older revision (Revision: v3.2.0) removed. This update is metadata about the platform version and does not affect the study record data.SummaryDifference0.1%

Stay in the know with updates to Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evorpacept Plus Pembrolizumab in Advanced Head & Neck SCC Clinical Trial page.